A new association of second-trimester echogenic bowel and metabolic disease of the neonate

Journal of Ultrasound in Medicine

Volumn 26, Issue 8, 2007, Pages 1119-1122

  Lee, Maureen ^a   Cook, Curtis R ^b   Wilkins, Isabelle ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SPECTRUM HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; DIAGNOSIS; DISEASES; ULTRASONOGRAPHY;

INTRAUTERINE GROWTH; METABOLIC DISEASE;

BIOMEDICAL ENGINEERING;

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; LONG CHAIN 3 HYDROXYLACYL COENZYME A DEHYDROGENASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ADULT; AMNIOCENTESIS; ARTICLE; CASE REPORT; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ENZYME DEFICIENCY; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS HYDROPS; GENE DELETION; GENE MUTATION; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; LACTIC ACIDOSIS; METABOLIC DISORDER; NEWBORN DEATH; NEWBORN DISEASE; PLEURA EFFUSION; PROTEIN DEFICIENCY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; STILLBIRTH;

EID: 34547664754     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.8.1119     Document Type: Article

References (23)

1. Hill LM, Fries J, Hecker J, Grysbeck P. Second trimester echogenic small bowel: an increased risk for adverse perinatal outcome. Prenat Diagn 1994; 14:845-850.
2. Simon-Bouy B, Satre V, Ferec C, et al. Hyperechogenicfetal bowel: a large French collaborative study of 682 cases. Am J Med Genet 2003; 121:209-213.
3. Al-Kouatly HB, Chasen ST, Streltzoff J, Chervenak FA. The clinical significance of fetal echogenic bowel. Am J Obstet Gynecol 2001; 185:1035-1038.
4. MacGregor SN, Tamura R, Sabbagha R, Brehofer JK, Kambich MP, Pergament E. Isolated hyperechoic fetal bowel: significance and implications for management. Am J Obstet Gynecol 1995; 173:1254-1258.
5. Bromley B, Doubilet P, Frigoletto FD, Krauss C, Estroff JA, Benacerraf BR. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis? Obstet Gynecol 1994; 83:647-651.
6. Nyberg DA, Dubinsky T, Resta RG, Mahony BS, Hickok DE, Luthy DA. Echogenic fetal bowel during the second trimester: clinical importance. Radiology 1993; 188: 527-531.
7. Ghose I, Mason GC, Martinez D, et al. Hyperechogenic fetal bowel: a prospective analysis of sixty consecutive cases. BJOG 2000; 107:426-429.
8. Strocker AM, Snijders RJ, Carlson DE, et al. Fetal echogenic bowel: parameters to be considered in differential diagnosis. Ultrasound Obstet Gynecol 2000; 16:519-523.
9. Achiron R, Seidman DS, Horowitz A, Mashiach S, Goldman B, Lipitz S. Hyperechogenic fetal bowel and elevated serum alpha-fetoprotein: a poor fetal prognosis. Obstet Gynecol 1996; 88:368-371.
10. Chandra S, Scott H, Dodds L, Watts C, Blight C, Van den Hof M. Unexplained elevated maternal serum α-fetoprotein and/or human chorionic gonadotropin and the risk of adverse fetal outcomes. Am J Obstet Gynecol 2003; 189: 775-781.
11. Yaron Y, Hassan S, Geva E, Kupferminc MJ, Yavetz H, Evans MI. Evaluation of fetal echogenic bowel in the second trimester. Fetal Diagn Ther 1999; 14:176-180.
12. Muller F, Dommergues M, Aubry MC, et al. Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome. Am J Obstet Gynecol 1995; 173:508-513.
13. Venditti CP, Stanley CA. Disorders of mitochondrial fatty acid metabolism. In: Behrman RE (ed). Nelson Textbook of Pediatrics. 17th ed. Philadelphia, PA: WB Saunders Co; 2004:435-436.
14. Lund AM, Leonard JV. Feeding difficulties in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Arch Dis Child 2001; 85:487-488.
15. Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006; 107:115-120.
16. den Boer ME, Wanders RJ, Morris AA, Ulst L, Heymans HS, Wijburg FA. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 2002; 109:99-104.
17. Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol 1998; 178:603-608.
18. Yang Z, Zhao Y, Bennett MJ, Strauss W, Ibdah JA. Fetal genotypes and pregnancy outcomes in 35 families with mitochondrial trifunctional protein mutations. Am J Obstet Gynecol 2002; 187:715-720.
19. Rakheja D, Bennett MJ, Foster BM, Domiati-Saad R, Rogers BB. Evidence for fatty acid oxidation in human placenta and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta 2002; 23:447-450.
20. Oey NA, den Boer ME, Wijburg FA, et al. Long-chain fatty acid oxidation during early human development. Pediatr Res 2005; 57:755-759.
21. Rinaldo P, Studinski AL, Matern D. Prenatal diagnosis of disorder of fatty acid transport and mitochondrial oxidation. Prenat Diagn 2001; 21:52-54.
22. Slotnick RN, Abuhamad AZ. Prognostic implications of fetal echogenic bowel. Lancet 1996; 347:85-87.
23. Dicke JM, Crane Jp. Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management. Obstet Gynecol 1992; 80:778-782.